×
About 1,838,602 results

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
https://jamanetwork.com/journals/jamacardiology/fullarticle/2768914

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
https://www.nature.com/articles/s41586-020-2577-1_reference.pdf

Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection
https://www.acpjournals.org/doi/10.7326/M20-3214

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
https://www.nature.com/articles/s41586-020-2598-9_reference.pdf
Nature

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the rapidly unfolding coronavirus disease 2019 (COVID-19) pandemic1,2 . Clinical manifestations of COVID-19 vary, ranging from asymptomatic infection to respiratory failure. The mechanisms determining such variable outcomes remain unresolved. Here, we investigated SARS-CoV-2 spike glycoprotein (S)-reactive CD4+ T cel...

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans
https://www.biorxiv.org/content/10.1101/2020.05.14.095414v1.full.pdf

Several related human coronaviruses (HCoVs) are endemic in the human population, causing mild respiratory infections1 . Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiologic agent of Coronavirus disease 2019 (COVID-19), is a recent zoonotic infection that has quickly reached pandemic spread2,3 . Zoonotic introduction of novel coronaviruses is thought to occur in the ...

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
https://journals.sagepub.com/doi/full/10.1177/2045894020920153

Open Data
https://opendata.ncats.nih.gov/covid19/

NCATS is generating a collection of datasets by screening a panel of SARS-CoV-2-related assays against all approved drugs These datasets, as well as the assay protocols used to generate them, are being made immediately available to the scientific community on this site as these screens are completed

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
https://www.biorxiv.org/content/10.1101/2020.04.21.053058v3

COVID-19: Operational guidance for maintaining essential health services during an outbreak
https://apps.who.int/iris/bitstream/handle/10665/331561/WHO-2019-nCoV-essential_health_services-2020.1-eng.pdf
WHO

Health systems are being confronted with rapidly increasing demand generated by the COVID-19 outbreak. When health systems are overwhelmed, both direct mortality from an outbreak and indirect mortality from vaccine-preventable and treatable conditions increase dramatically. Analyses from the 2014-2015 Ebola outbreak suggest that the increased number of deaths caused by measles, malaria, HIV/...

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
https://www.nejm.org/doi/full/10.1056/NEJMc2016359

Humoral Immune Response to SARS-CoV-2 in Iceland
https://www.nejm.org/doi/full/10.1056/NEJMoa2026116

Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020
https://jamanetwork.com/journals/jama/fullarticle/2764137
JAMA

Until recently, diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was only available through public health laboratories.1-3 This limited testing was prioritized for persons who had severe illness or identifiable risk factors, such as travel to an area with ongoing transmission. Thus, the incidence of c...

Introductions and early spread of SARS-CoV-2 in the New York City area
https://science.sciencemag.org/content/369/6501/297
Science

New York City (NYC) has emerged as one of the epicenters of the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission events underlying the rapid spread of the virus in the NYC metropolitan area, we sequenced the virus that causes coronavirus disease 2019 (COVID-19) in patients seeking care at the Mount Sinai Health System. Phylogeneti...

Effect of statins on SARS-CoV-2 infection
https://www.medrxiv.org/content/10.1101/2020.07.13.20152272v1.full.pdf

Antihypertensive drugs and risk of COVID-19?
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30153-3/fulltext
The Lancet Respiratory Medicine;

Mar 25th, 2020 - Lei Fang and colleagues1 suggest that clinicians should consider withholding angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) because of a potential increased risk of worse clinical outcomes in patients with coronavirus disease 2019 (COVID-19), and they suggest calcium channel blockers as an alternative. The hypothesis behind this suggestion is that the e...

SARS-CoV-2 Reference Panel Comparative Data
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data

The FDA SARS-CoV-2 Reference Panel allows for a more precise comparison of the analytical performance of different molecular in vitro diagnostic (IVD) assays intended to detect SARS-CoV-2. The Reference Panel contains common, independent, and well-characterized reference material that is available to developers of SARS-CoV-2 nucleic acid-based amplification tests (NAATs) for which Emergency Use...

Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/statement-on-astrazeneca-oxford-sars-cov-2-vaccine-azd1222-covid-19-vaccine-trials-temporary-pause.html

As part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a standard review process has been triggered, leading to the voluntary pause of vaccination across all trials to allow an independent committee to review the safety data of a single event of an unexplained illness that occurred in the UK Phase III trial. This is a routine act...

Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
https://jamanetwork.com/journals/jamacardiology/fullarticle/2770645

Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function.1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), even in asymptomatic or mildly symptomatic patients.2 Our objective was to investigate the use of cardiac magnetic resonance (CMR) imaging in com...

COVID-19: the older adult and the importance of vitamin D sufficiency
https://www.cambridge.org/core/journals/journal-of-nutritional-science/article/covid19-the-older-adult-and-the-importance-of-vitamin-d-sufficiency/B42BD7C0EE9090DA30B916AF52FD713F

In December 2019, in Wuhan, China, the novel coronavirus ‘severe acute respiratory syndrome 2’ (SARS-CoV-2) was discovered as the cause of a pneumonia-like illness and subsequently named coronavirus disease 2019 (COVID-19). COVID-19 spread and is now a global pandemic. With few exceptions, countries in the Northern hemisphere have higher mortality rates from COVID-19. This may be due to an incr...

ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection
https://www.medrxiv.org/content/10.1101/2020.02.12.20022418v1

In December 2019 and January 2020, novel coronavirus (2019-nCoV) - infected pneumonia (NCIP) occurred in Wuhan, and has already posed a serious threat to public health. ACE2 (Angiotensin Converting Enzyme 2) has been shown to be one of the major receptors that mediate the entry of 2019-nCoV into human cells, which also happens in severe acute respiratory syndrome coronavirus (SARS). Several res...